AMAZE™ Asthma Implementation QI Study

Trial Identifier: N3566000000
Sponsor: AstraZeneca
Collaborator:
Greater Austin Allergy
Evidera, Inc.
NCTID:: NCT04901260
Start Date: November 2020
Primary Completion Date: June 2021
Study Completion Date: June 2021
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
United States of America, TX Austin, TX, United States of America, 78746
United States of America, TX Austin, TX, United States of America, 78730